PHASE II STUDY OF 9-AMINOCAMPTOTHECIN (9-AC/DMA, NSC 603071) IN PREVIOUSLY TREATED HODGKIN'S DISEASE AND NON-HODGKIN'S LYMPHOMA: IWF GRADES A-H.

Trial Profile

PHASE II STUDY OF 9-AMINOCAMPTOTHECIN (9-AC/DMA, NSC 603071) IN PREVIOUSLY TREATED HODGKIN'S DISEASE AND NON-HODGKIN'S LYMPHOMA: IWF GRADES A-H.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Feb 2013

At a glance

  • Drugs IDEC 132 (Primary)
  • Indications Hodgkin's disease; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Nov 2008 Status changed from active, no longer recruiting to completed, based on information from ClinicalTrials.gov.
    • 11 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top